- Home
- TAOP vs ATXI Comparison
TAOP vs ATXI Comparison
Compare TAOP & ATXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- ATXI
- Stock Information
- Founded
- TAOP 1993
- ATXI 2015
- Country
- TAOP China
- ATXI United States
- Employees
- TAOP N/A
- ATXI N/A
- Industry
- TAOP Computer Software: Prepackaged Software
- ATXI Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- ATXI Health Care
- Exchange
- TAOP Nasdaq
- ATXI Nasdaq
- Market Cap
- TAOP 2.5M
- ATXI 3.0M
- IPO Year
- TAOP N/A
- ATXI 2017
- Fundamental
- Price
- TAOP $0.36
- ATXI $1.93
- Analyst Decision
- TAOP
- ATXI Strong Buy
- Analyst Count
- TAOP 0
- ATXI 1
- Target Price
- TAOP N/A
- ATXI $56.25
- AVG Volume (30 Days)
- TAOP 750.2K
- ATXI 78.9K
- Earning Date
- TAOP 09-05-2024
- ATXI 11-14-2024
- Dividend Yield
- TAOP N/A
- ATXI N/A
- EPS Growth
- TAOP N/A
- ATXI N/A
- EPS
- TAOP 0.50
- ATXI N/A
- Revenue
- TAOP $42,636,173.00
- ATXI N/A
- Revenue This Year
- TAOP N/A
- ATXI N/A
- Revenue Next Year
- TAOP N/A
- ATXI N/A
- P/E Ratio
- TAOP $0.57
- ATXI N/A
- Revenue Growth
- TAOP 37.49
- ATXI N/A
- 52 Week Low
- TAOP $0.33
- ATXI $1.60
- 52 Week High
- TAOP $2.01
- ATXI $26.48
- Technical
- Relative Strength Index (RSI)
- TAOP 32.81
- ATXI 38.77
- Support Level
- TAOP $0.33
- ATXI $1.97
- Resistance Level
- TAOP $0.51
- ATXI $2.41
- Average True Range (ATR)
- TAOP 0.04
- ATXI 0.19
- MACD
- TAOP -0.00
- ATXI -0.03
- Stochastic Oscillator
- TAOP 20.00
- ATXI 34.02
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About ATXI Avenue Therapeutics Inc.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.